George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.70
Ask: 3.80
Change: -0.05 (-1.32%)
Spread: 0.10 (2.703%)
Open: 3.80
High: 3.80
Low: 3.75
Prev. Close: 3.80
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London Investor Symposium

23 May 2019 07:00

RNS Number : 9058Z
Polarean Imaging PLC
23 May 2019
 

Polarean Imaging Plc 

("Polarean" or the "Company")

 

London Investor Symposium

Wednesday 12 June 2019

 

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, announces it will be hosting a Capital Markets Day for all investors on Wednesday 12 June 2019.

 

A welcome and introduction will be given by Richard Morgan, Chairman of Polarean Imaging. The morning will also feature presentations by:

 

· Bastiaan Driehuys, PhD, Founder and Chief Technology Officer

· Richard Hullihen, CEO of Polarean Imaging

· Jason Woods, PhD, Director at the Center for Pulmonary Imaging Research at Cincinnati Children's Medical Center

· Sudarshan Rajagopal, MD, PhD, Duke University (pre-recorded presentation)

 

The event will take place at the London Stock Exchange, 10 Paternoster Square, London EC4M 7LS at 9.30am, when a light breakfast will be served, for a 10.00am start. Please be aware that all visitors will require photo identification and will be subject to a brief security check on arrival to the building so allow sufficient time for this.

 

The presentations will be followed by tea and coffee, and a chance to network with all members of the Company's management team in attendance.

 

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email polarean@walbrookpr.com.

 

Enquiries:

 

Polarean Imaging plc

www.polarean.com / www.polarean-ir.com

Richard Hullihen, Chief Executive Officer

Via Walbrook PR

Richard Morgan, Chairman

Walbrook PR

Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com

Anna Dunphy / Paul McManus

Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAQLLFLKEFFBBB
Date   Source Headline
25th Jul 20193:31 pmRNSResult of AGM
24th Jul 20192:45 pmRNSExercise of Warrants
22nd Jul 201910:00 amRNSPlacing to raise £2.1 million
11th Jul 20197:00 amRNSNew System Order
27th Jun 20197:00 amRNSFinal Results
13th Jun 20195:02 pmRNSInvestor Symposium presentations available online
11th Jun 20197:00 amRNSPhase III Clinical Trials - Update
5th Jun 20197:00 amRNSNew System Order
23rd May 20193:26 pmRNSGrant of Share Options
23rd May 20197:00 amRNSLondon Investor Symposium
21st May 20197:00 amRNS3rd tranche of $3m pediatric study grant confirmed
13th May 20197:00 amRNSClinical trial update
30th Apr 20197:00 amRNSTotal Voting Rights
29th Apr 20197:00 amRNSAppointment of Chief Financial Officer
2nd Apr 20197:00 amRNSExercise of Warrants
1st Apr 20197:00 amRNSAmphion Innovations - Pledge of Polarean shares
15th Feb 20197:00 amRNSNew System Order
24th Jan 20197:00 amRNSAppointment of Nominated Adviser and Broker
21st Jan 20193:36 pmRNSHolding(s) in Company
3rd Jan 20197:00 amRNSHolding(s) in Company
28th Dec 20182:52 pmRNSResult of General Meeting and Total Voting Rights
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
11th Dec 20187:00 amRNSConditional Fundraise to raise US$4 million
13th Nov 20187:00 amRNSLicencing Agreement with Duke University
6th Nov 20187:00 amRNSCompany update
5th Nov 20187:00 amRNSNominated Adviser Status
3rd Oct 20187:00 amRNSDelivery of Xenon Polariser
23rd Aug 20187:00 amRNSFIRST PATIENT IN PHASE III FDA CLINICAL TRIAL
22nd Aug 20187:00 amRNSHalf-year Report
27th Jul 20187:00 amRNSCompany update
18th Jul 20182:28 pmRNSResult of AGM
17th Jul 20182:49 pmRNSHolding(s) in Company
10th Jul 20183:22 pmRNSResult of Placing
9th Jul 20182:41 pmRNSProposed Placing to raise a minimum of £0.78m
21st Jun 201810:12 amRNSHolding(s) in Company
19th Jun 20184:40 pmRNSSecond Price Monitoring Extn
19th Jun 20184:35 pmRNSPrice Monitoring Extension
19th Jun 20187:00 amRNSInvestor Symposium
13th Jun 20187:00 amRNSFinal Results
6th Jun 20187:00 amRNSDelivery of Xenon Polariser
31st May 20187:00 amRNSLondon Investor Symposium
22nd May 20187:00 amRNSDelivery of Xenon Polariser
20th Apr 20187:00 amRNSGrant of Share Options
17th Apr 20187:00 amRNSPolarean technology used in severe asthma study
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.